The present invention provides a compound of formula I: ##STR00001## or a pharmaceutically acceptable salt thereof. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of utilizing those compounds and compositions in the treatment of various protein kinase mediated disorders.

 
Web www.patentalert.com

> Compositions containing lysophosphotidic acids which inhabit apoptosis and uses thereof

~ 00371